EA201991746A1 - PYRAZOLE DERIVATIVES AS BROMODOMENE INHIBITORS - Google Patents

PYRAZOLE DERIVATIVES AS BROMODOMENE INHIBITORS

Info

Publication number
EA201991746A1
EA201991746A1 EA201991746A EA201991746A EA201991746A1 EA 201991746 A1 EA201991746 A1 EA 201991746A1 EA 201991746 A EA201991746 A EA 201991746A EA 201991746 A EA201991746 A EA 201991746A EA 201991746 A1 EA201991746 A1 EA 201991746A1
Authority
EA
Eurasian Patent Office
Prior art keywords
bromodomene
inhibitors
pyrazole derivatives
compounds
pyrazole
Prior art date
Application number
EA201991746A
Other languages
Russian (ru)
Other versions
EA038888B1 (en
Inventor
Стивен Джон Аткинсон
Эммануэль Юбер Демон
Ли Эндрю Харрисон
Джемма Мишель Ливики
Саймон Кристофер Кранко Лукас
Александер Дж Престон
Джонатан Томас Сиал
Иан Дэвид Уолл
Роберт Дж Ватсон
Original Assignee
Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед filed Critical Глаксосмитклайн Интеллекчуал Проперти (№2) Лимитед
Priority claimed from PCT/EP2018/054733 external-priority patent/WO2018158212A1/en
Publication of EA201991746A1 publication Critical patent/EA201991746A1/en
Publication of EA038888B1 publication Critical patent/EA038888B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Abstract

Настоящее изобретение относится к производным пиразола, фармацевтическим композициям, содержащим эти соединения, и применению этих соединений или композиций в лечении различных заболеваний.The present invention relates to pyrazole derivatives, pharmaceutical compositions containing these compounds, and the use of these compounds or compositions in the treatment of various diseases.

EA201991746A 2017-10-06 2018-02-27 Pyrazole derivatives as bromodomain inhibitors EA038888B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1716374.2A GB201716374D0 (en) 2017-10-06 2017-10-06 Compounds
PCT/EP2018/054733 WO2018158212A1 (en) 2017-03-01 2018-02-27 Pyrazole derivatives as bromodomain inhibitors

Publications (2)

Publication Number Publication Date
EA201991746A1 true EA201991746A1 (en) 2020-01-30
EA038888B1 EA038888B1 (en) 2021-11-02

Family

ID=60326742

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991746A EA038888B1 (en) 2017-10-06 2018-02-27 Pyrazole derivatives as bromodomain inhibitors

Country Status (2)

Country Link
EA (1) EA038888B1 (en)
GB (1) GB201716374D0 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1433788A1 (en) * 2002-12-23 2004-06-30 Aventis Pharma Deutschland GmbH Pyrazole-derivatives as factor Xa inhibitors
GB0919434D0 (en) * 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
JP2016507496A (en) * 2012-12-21 2016-03-10 ゼニス・エピジェネティクス・コーポレイションＺｅｎｉｔｈ Ｅｐｉｇｅｎｅｔｉｃｓ Ｃｏｒｐ． Novel heterocyclic compounds as bromodomain inhibitors

Also Published As

Publication number Publication date
EA038888B1 (en) 2021-11-02
GB201716374D0 (en) 2017-11-22

Similar Documents

Publication Publication Date Title
CY1124084T1 (en) AMIDE SUBSTITUTED PYRIDINYLTRIAZOLE DERIVATIVES AND USES THEREOF
MY196909A (en) Boronic acid derivatives and therapeutic uses thereof
EA201891203A1 (en) HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
EA201692301A1 (en) DERIVATIVES OF BORONIC ACID AND THEIR THERAPEUTIC APPLICATION
EA201792047A1 (en) NEW CONNECTIONS
EA201790951A1 (en) DERIVATIVES OF HYDROXYLKYL SUBSTITUTED PHENILTRIASOLE AND THEIR USE
EA201790170A1 (en) THERAPEUTIC COMPOUNDS INHIBITORS
EA201691590A1 (en) BENZIMIDAZOL-2-AMINES AS MIDHI INHIBITORS
EA201891063A1 (en) DERIVATIVES OF DIHYDROIMIDAZOPIRAZINONE APPLICABLE IN THE TREATMENT OF CANCER
EA201790085A1 (en) INHIBITORS OF LYSINE-SPECIFIC DEMETILASE-1
EA201692313A1 (en) Derivatives of indolysine as inhibitors of phosphosinositide-3-kinase
EA201790082A1 (en) INHIBITORS OF LYSINE-SPECIFIC DEMITILASE-1
EA201992504A1 (en) MAGL INHIBITORS BASED ON PYRAZOL
EA201890331A1 (en) PYRIDINODICARBOXAMIDES FOR APPLICATION AS BROMODOUM INHIBITORS AS
CY1125179T1 (en) PYRAZOLE DERIVATIVES USEFUL AS 5-LIPOXYGENASE ACTIVATING PROTEIN (FLAP) INHIBITORS
EA201692481A1 (en) COMBINATION CONTAINING GLUCOCORTICOID AND EDO-S101
EA201692474A1 (en) DERIVATIVES 1- (CYCLOPENT-2-EN-1-IL) -3- (2-HYDROXY-3- (ARYLSULFONIL) PHENYL) URECHEN AS CXCR2 Inhibitors
EA201690783A1 (en) SUBSTANCES, PHARMACEUTICAL COMPOSITION AND METHODS OF APPLICATION IN THE TREATMENT OF INFLAMMATORY DISEASES
EA201792057A1 (en) CONDENSED BICYCLIC HETEROYARIL DERIVATIVES WITH ACTIVITY OF PROHYLDROXYLASE INHIBITORS
EA202191478A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
EA202190588A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
EA201691962A1 (en) AMIDOSED NITROGEN COMPOUNDS AS TNKS1 AND / OR TNKS2 INHIBITORS
EA201890906A1 (en) DERIVATIVES OF CHINOXALINE AND PYRIDOPYRASINE AS PI3Kβ INHIBITORS
EA201501187A1 (en) NEW CHEMICAL COMPOUNDS (OPTIONS) AND THEIR APPLICATION FOR THE TREATMENT OF CANCER DISEASES